Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal Zinc Alpha 2 Glycoprotein antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
ZAG, ZNGP1, AZGP1, Zinc-alpha-2-glycoprotein, Zn-alpha-2-GP, Zn-alpha-2-glycoprotein
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] (AB180574)
Immunohistochemical analysis of Human liver tissue labeling Zinc Alpha 2 Glycoprotein with ab180574 at 1/250 dilution. Prediluted (ready to use) HRP Polymer for Rabbit IgG was used as a secondary antibody. Counter stain : Hematoxylin.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] (AB180574)
Immunoprecipitation of Human plasma labeling Zinc Alpha 2 Glycoprotein using ab180574at a 1/30 dilution (lane 1). Lane 2 shows the negative control. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as a secondary antibody at a dilution of 1/1500.
Blocking/dilution buffer and concentration : 5% NFDM/TBST
All lanes:
Immunoprecipitation - Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] (ab180574) at 1/30 dilution
Lane 1:
Human plasma
Lane 2:
Negative control
Secondary
All lanes:
Anti-Rabbit (HRP) specific to the non-reduced form of IgG at 1/500 dilution
Predicted band size: 34 kDa
false
- WB
Supplier Data
Western blot - Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] (AB180574)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] (ab180574) at 1/20000 dilution
All lanes:
Human plasma at 20 µg
Secondary
All lanes:
Anti-rabbit (HRP) specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 34 kDa
false
- WB
Supplier Data
Western blot - Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] (AB180574)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] (ab180574) at 1/2000 dilution
All lanes:
HepG2 cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-rabbit HRP at 1/1000 dilution
Predicted band size: 34 kDa
false
Related conjugates and formulations (1)
-
Anti-Zinc Alpha 2 Glycoprotein antibody [EPR14425(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Zinc Alpha 2 Glycoprotein assists in lipid metabolism. It promotes the breakdown of triglycerides in adipose tissue by stimulating the beta-adrenergic pathway. ZAG functions independently and does not typically form complexes with other proteins during this process. Its presence in adipose tissue suggests a role in energy homeostasis and body weight regulation.
Pathways
Zinc Alpha 2 Glycoprotein participates in the metabolic pathway for lipid degradation. The protein interacts with beta-3 adrenergic receptors to trigger lipolysis which involves breaking down fat cells into free fatty acids and glycerol. Its action in this pathway links ZAG with other proteins such as perilipin which protects lipid droplets from breakdown.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine (Cambridge, Mass.) 31:295 PubMed41013181
2025
Applications
Unspecified application
Species
Unspecified reactive species
Open life sciences 19:20221007 PubMed39711976
2024
Applications
Unspecified application
Species
Unspecified reactive species
Liver international : official journal of the International Association for the Study of the Liver 42:696-709 PubMed34854209
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 16:691-703 PubMed25561225
2015
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com